Tumor cell-intrinsic activity of the RNA receptor RIG-I promotes checkpoint inhibitor-mediated anticancer immunity

被引：0

作者：

Heidegger, S. ^{[1
]}

Wintges, A. ^{[1
]}

Stritzke, F. ^{[1
]}

Bek, S. ^{[1
]}

Steiger, K. ^{[2
]}

Winter, C. ^{[3
]}

Rad, R. ^{[4
]}

van den Brink, M. R. M. ^{[5
]}

Ruland, J. ^{[3
]}

Bassermann, F. ^{[1
]}

Chan, T. ^{[6
]}

Haas, T. ^{[1
]}

Poeck, H. ^{[1
]}

机构：

[1] Tech Univ Munich, Klinikum Rechts Isar, Med Klin & Poliklin 3, Munich, Germany

[2] Tech Univ Munich, Inst Allgemeine Pathol & Pathol Anat, Klinikum Rechts Isar, Munich, Germany

[3] Tech Univ Munich, Inst Klin Chem & Pathobiochem, Klinikum Rechts Isar, Munich, Germany

[4] Tech Univ Munich, Inst Mol Oncol & Funct Genom, Klinikum Rechts Isar, Munich, Germany

[5] Mem Sloan Kettering Canc Ctr, Dept Immunol & Med, 1275 York Ave, New York, NY 10021 USA

[6] Mem Sloan Kettering Canc Ctr, Immunogen & Precis Oncol, 1275 York Ave, New York, NY 10021 USA

来源：

ONCOLOGY RESEARCH AND TREATMENT | 2019年 / 42卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

V903

引用

页码：247 / 247

页数：1

共 50 条

[1] Role of melanoma cell-intrinsic RIG-I and STING signaling for checkpoint inhibitor-mediated anticancer immunity.
Heidegger, Simon
Wintges, Alexander
Bek, Sarah
Schmickl, Martina
Fischer, Julius
Koenig, Paul-Albert
Haas, Tobias
Poeck, Hendrik
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
[2] Tumor-Intrinsic RIG-I Signaling Promotes Anti-CTLA-4 Checkpoint Inhibitor-Mediated Anticancer Immunity
Heidegger, Simon
Wintges, Alexander
Bek, Sarah
Schmickl, Martina
Ruland, Juergen
van den Brink, Marcel R. M.
Peschel, Christian
Haas, Tobias
Poeck, Hendrik
BLOOD, 2017, 130
[3] Tumor cell-intrinsic Gasdermin E (GSDME) activation contributes to checkpoint inhibitor-mediated anticancer immunity
Enssle, S.
Perl, M.
Nedelko, T.
Krieger, M.
Bassermann, F.
Poeck, H.
Heidegger, S.
ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 : 35 - 36
[4] Anti-CTLA-4 checkpoint inhibitormediated anticancer immunity relies on tumor-intrinsic RIG-I signaling
Heidegger, S.
Wintges, A.
Bek, S.
Schmickl, M.
Steiger, K.
Koenig, P. -A.
Ruland, J.
van den Brink, M. R. M.
Peschel, C.
Haas, T.
Poeck, H.
ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 206 - 206
[5] Tumor Cell-intrinsic Activation of the Immune Receptor RIG-I in Combination with Immune Checkpoint Blockade improves anti-Tumor T-Cell Responses
Thier, B.
Such, L.
Sucker, A.
Coch, C.
Hartmann, G.
Schadendorf, D.
Griewank, K.
Trilling, M.
Zhao, F.
Paschen, A.
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2020, 18 : 10 - 10
[6] Tumor cell-intrinsic RIG-I signaling governs synergistic effects of immunogenic cancer therapies and checkpoint inhibitors in mice
Poeck, Hendrik
Wintges, Alexander
Dahl, Sarah
Bassermann, Florian
Haas, Tobias
Heidegger, Simon
EUROPEAN JOURNAL OF IMMUNOLOGY, 2021, 51 (06) : 1531 - 1534
[7] Activation of the cytosolic RNA receptor RIG-I in tumor and immune cells triggers efficient anti-tumor immunity and synergizes with checkpoint blockade
Heidegger, S.
Alexander, W.
Kreppel, D.
Bscheider, M.
Bek, S.
Fischer, J.
Schmickl, M.
Ruland, J.
Peschel, C.
Haas, T.
Poeck, H.
EUROPEAN JOURNAL OF CANCER, 2016, 55 : S22 - S22
[8] RIG-I like receptor sensing of host RNAs facilitates the cell-intrinsic immune response to KSHV infection
Zhao, Yang
Ye, Xiang
Dunkert, William
Song, Yu
Karijolich, John
NATURE COMMUNICATIONS, 2018, 9
[9] RIG-I like receptor sensing of host RNAs facilitates the cell-intrinsic immune response to KSHV infection
Yang Zhao
Xiang Ye
William Dunker
Yu Song
John Karijolich
Nature Communications, 9
[10] The RNA receptor RIG-I binding synthetic oligodeoxynucleotide promotes survival
Wang, Yongxing
V. Kulkarni, Vikram
Pantaleongarcia, Jezreel
Longmire, Michael K.
Lethier, Mathilde
Cusack, Stephen
Evans, Scott E.
JCI INSIGHT, 2024, 9 (21)

← 1 2 3 4 5 →